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Objective: the aim of this study was to establish at which point during a hospital admission MRSA acquisition occurs in
vascular patients.
Method: a consecutive series of 100 patients undergoing arterial surgery were screened for MRSA carriage on admission to
hospital, on exit from theatre, on discharge from ITU, weekly whilst an inpatient and on hospital discharge. Screening was
with moistened swabs from nose, throat, perineum and open wounds that were pooled for microbiological culture.
Results: four patients (4%) screened positive for MRSA on admission to hospital. Of the remaining 96, 16 (17%) acquired
MRSA during their hospital stay as follows: exit from theatre, one; exit from ITU, six; on the ward postoperatively, nine.
Comparing MRSA acquisition (n 16) with non acquisition (n 80) the following characteristics were noted, length of
stay 16 (4±66) vs 7 (2±50) days (Mann±Whitney p5 0.001); admission to ITU 13/16 vs 46/80 (Fishers chi-squared
p 0.10); length of ITU stay 3 (1±20) vs 3 (1±14) days (Mann±Whitney p 0.41). Frequent hospital attendance, age,
emergency admission, diabetes or renal failure were not commoner in those with MRSA acquisition.
Conclusions: these data indicate that 4% of patients undergoing arterial surgery are pre-existing carriers of MRSA.
Length of hospital stay is the single most important determinant of MRSA acquisition.
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Methicillin-resistant Staphylococcus aureus (MRSA) is
now the commonest cause of surgical site infection
in vascular patients.1,2 MRSA infection in vascular
patients is associated with an overall poor outcome,
and although prosthetic implants are at particular risk
vein grafts are not immune. The treatment of prosthetic
graft MRSA infection carries with it high rates of limb
loss and mortality.3±7 It is acknowledged that a reser-
voir of MRSA exists in community nursing homes8
and in chronic ulcer clinics in both the U.K.9 and
France.10 Although the prevalence of MRSA carriage
and infection is rising in the hospitals of Europe and
the U.S.A., no data exist describing the timing of
MRSA acquisition during a period of hospital admis-
sion. The aim of this study was to establish the point
of MRSA acquisition during the course of an inpatient
stay on our vascular unit.Please address all correspondence to: J. M. Scriven, Department of
Vascular Surgery, Robert Kilpatrick Clinical Sciences Building,
University of Leicester, Leicester Royal Infirmary, Leicester,
LE1 5WW, U.K.
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Patients
With local ethical committee approval a consecutive,
prospective, series of 100 patients were studied. This
series represented admissions to a single site vascular
unit at the Leicester Royal Infirmary over a 6 month
period with the exclusion of patients undergoing vari-
cose vein or endocrine surgery or patients undergoing
percutaneous balloon angioplasty. All patients studied
underwent an arterial surgical procedure as follows:
open aortic aneurysm repair (AAA), 35; endovascular
aortic aneurysm repair (endAAA), seven: carotid
endarterectomy (CEA), 26; infra-inguinal bypass
(IIB), 10; lower limb inflow procedure (LLI), 14;
major amputation (MA), five and removal of infected
graft, three. MRSA colonisation was defined as the
culture of MRSA from pooled swabs in the absence
of symptoms or signs of tissue destruction. MRSA
infection was defined as the isolation of MRSA
from a site associated with tissue destruction or from
blood, sputum or urine cultures.11 All patients
received a standard regimen of antibiotic prophylaxisrights reserved.
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500 mg were administered intravenously on induction
of anaesthesia followed by two post operative intra-
venous doses of cefuroxime 750 mg and metronida-
zole 500 mg. Patients known to carry MRSA were also
given a single dose of intravenous vancomycin 1 g on
induction. As the results of the screening swabs were
only available several days post operatively these
results could not influence our antibiotic policies.
Screening swabs
All patients were screened for MRSA at three or four
time points during the study as follows: (1) on arrival
in the hospital. This was carried out within one hour
of arriving in the hospital and indicates the MRSA
status of the patient pre-admission. (2) On exit from
the operating theatre, this indicates whether the
patient acquired MRSA on the general ward pre-
operatively or during the surgery in the operating
theatre. (3) On discharge from the intensive/high
dependency care unit (ITU/HDU), a positive swab at
this time point indicates that the patient acquired
MRSA on the ITU. (4) Weekly on the postoperative
ward and on discharge from hospital to indicate
whether MRSA was acquired during the postopera-
tive period. Only patients admitted to the ITU/HDU
would return a set of screening swabs taken at that
time point.
As recommended by The Combined Working Party
of the British Society for Antimicrobial Chemotherapy,
the Hospital Infection Society and the Infection
Control Nurses Association11 the MRSA screening
swabs were standardised for each patient. The ana-
tomical sites screened for MRSA included the nose,100 
patients
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Fig. 1. Breakdown of swab results for all 100 patients studied.
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bing was performed using standard bacteriology
swabs moistened with sterile saline, and samples
from each separate anatomical site were pooled for
bacteriological examination.
Bacteriological processing
Pooled swabs from individual patients were primarily
cultured in 2% Salt Nutrient Broth at 30 C for 18 h.
Broths were then subcultured on to Salt Agar nutrient
plates with mannitol and methicillin (4 mg/l) over-
night at 37 C. Mannitol fermenting isolates were
identified by DNAse activity and methicillin suscep-
tibility testing.
Results
All one hundred patients completed the study. Four
(4%) patients were found to be MRSA positive on their
admission swab, a further 16 patients acquired MRSA
during their hospital stay (Fig. 1).
Of the four patients screening positive for MRSA on
admission, three patients were already known to be
MRSA positive (two with overt prosthetic graft infec-
tion and one simple colonisation) and one patient was
identified as a new carrier of MRSA. The newly iden-
tified MRSA positive patient was an elective admis-
sion for vein bypass grafting of a popliteal artery
aneurysm. This patient remained positive throughout
the hospital stay but developed no complications.
Of the remaining 96 patients 16 (17%) subsequently
screened positive for MRSA after hospital admission.
The timing of the first MRSA positive swabs and the96 MRSA
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MRSA in Vascular Patients 149procedures performed were as follows: exit from
theatre, one patient (AAA) repair; discharge from
ITU, six patients (1 MA, 1 CEA, 4 AAA); on the
ward postoperatively, nine patients (4 AAA, 3 MA,
1 CEA, 1 endAAA). Six of these 16 patients demon-
strated MRSA colonisation only and 10 developed
frank MRSA infection. These MRSA infections were
as follows: four postoperative chest infections, four
postoperative wound infections (Szylagi I ± two
patients, Szylagi II ± two patients, none developed
Szylagi III wounds12), one bacteraemia, one infected
chylous ascites.
Turning to the risk factors displayed by these 96
patients. The proportion of patients acquiring MRSA
in hospital who were admitted as emergencies or to
the ITU or who had diabetes or renal impairment were
comparable to the proportion who did not acquire
MRSA. The only significant factor identified with
MRSA acquisition was a prolonged length of hospital
stay. Neither age, length of ITU stay, nor number of
outpatient hospital visits appeared to be associated
with MRSA acquisition (Table 1). Of the 12 patients
who acquired MRSA and were admitted to the ITU,
six acquired MRSA on the ITU with a median (range)
ITU stay of 7 (1±20) days. The six patients who were
admitted to the ITU but acquired MRSA elsewhere
spent a median (range) 3 (1±7) days on the ITU.
There was no significant difference in these two
lengths of stay (Mann±Whitney U-test Zÿ0.66,
p 0.51). Of these 100 patients, 34 had been hospital
inpatients for at least one day prior to the admission
under investigation. Of these 34 patients, none had
previously been noted to be MRSA positive. During
this study, five acquired MRSA after admission and
29 did not.
In addition to the MRSA isolates above a further
nine patients produced microbiological isolates of
methicillin sensitive Staphylococcus aureus (MSSA)Table 1. Examination of risk factors between patients free of
MRSA (n 80) and those acquiring MRSA (n 16).
Risk factor MRSAÿ
(n 80), (%)
MRSA
(n 16), (%)
p
ITU admission 46 (58) 13 (80) 0.10 
Diabetic 9 (11) 3 (19) 0.40 
Renal impairment 14 (18) 3 (19) 0.72 
Emergency admission 9 (11) 4 (25) 0.22 
Age 71 (23±83) 76 (53±87) 0.09 y
Inpatient stay 7 (2±50) 16 (4±66) <0.001 y
ITU stay 3 (0±14) 3 (1±20) 0.41 y
Outpatient visits prior
to operation
3 (1±20) 2 (1±8) 0.64 y
 Fisher's Exact test.
yMann±Whitney U-test.and one of Pseudomonas sp. Of the nine patients who
acquired MSSA, three had frank infection and six
asymptomatic colonisation. The single case of
pseudomas infection was an active postoperative
chest infection.
Discussion
This study was performed because of our anecdotal
perception that many vascular patients were acquir-
ing MRSA during the period spent on the ITU. The
data presented here demonstrate that this is not the
case, and that MRSA can be acquired from all hospital
areas at any stage during admission. It is clear that
peri-operative bacterial colonisation is very common
(20% MRSA, 10% MSSA/other) and with this the rate
of postoperative infective complications is high (10%
MRSA, 4% other). As far as we are aware this is the
first paper to prospectively examine the timing of
MRSA acquisition during hospital admission.
Considering that 17% of elderly residents in
Nursing homes in the West Midlands are colonised
by MRSA8 and that 15% of diabetic foot ulcers are
colonised by MRSA,9 it is encouraging that only 1%
of admissions to the vascular unit were previously
unidentified MRSA carriers. The most frequent time
period where MRSA acquisition occurred was in the
postoperative period on the general ward (9/16
MRSA positive patients (56%)). This and the finding
that the only significant risk factor in MRSA acquisi-
tion was the length of hospital stay suggest that the
common factor in these cases is the degree of direct
contact between the patient and hospital staff. Patients
who remain an inpatient for a prolonged period are
usually more unwell and require more handling by
nursing staff and more `` hands on'' attention from the
medical staff than those patients whose recovery is
less complicated. Thus, there are more opportunities
to transfer MRSA. This degree of patient contact is
important, as the most useful method to limit MRSA
cross infection is careful hand hygiene between each
episode of patient contact.13±15 This theory is sup-
ported by the observation that 2/26 patients who
underwent CEA developed MRSA infection. This is a
procedure usually associated with a short postopera-
tive stay. The two patients involved had prolonged
post operative hospital stays of four and nine days
because of post operative hypertension. Of the
remaining 24 patients the median (range) stay was
3 (2±12) days. It is noteworthy that some patients
acquired MRSA despite undergoing procedures that
are usually associated with relatively shorter hospital
stays (CEA, elective AAA repairs). The fact that theseEur J Vasc Endovasc Surg Vol 25, February 2003
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reducing the MRSA pool in the ward and observing
careful hand and environmental hygiene. The geo-
graphy of the vascular ward in our unit lends itself
to the isolation of cases known to be carriers of MRSA
into side rooms. Other patients are nursed in six
bedded bays with a high bed occupancy rate that
may influence the efficacy of general ward cleaning
and hygiene procedures. A criticism of this argument
is that the patients' length of stay was prolonged
because of the MRSA colonisation but our experience
of discharging patients to the community is not sig-
nificantly delayed in cases where the patient is MRSA
positive. Thus the pool in hospital inpatient MRSA is
minimised as far as possible.
Traditionally emergency surgery predisposes to
infective postoperative complications, however, only
two cases of AAA were emergency admissions of
which one acquired MRSA. Similarly, infra-inguinal
bypass grafts are often performed in patients at high
risk of postoperative infection because of diabetes,
renal impairment and tissue loss. Of the 10 IIB
patients only one acquired MRSA during their stay.
This data may contradict experience in other centers
but may be a reflection of the small numbers of emer-
gency and infra inguinal cases in this series.
This study has raised several issues regarding
patient management. Essentially, should patients
undergoing arterial surgery be screened pre-
operatively and those found to be positive for MRSA
undergo eradication therapy? The consequences of
MRSA infection are severe and the answer ought to
be yes. However, only one case (1%) of previously
unrecognised MRSA carriage was identified and this
patient developed no infective complications. Of the
three other cases of pre-operative MRSA carriage two
had established MRSA graft infection and in these
cases surgery was a necessary component of MRSA
eradication and all three cases were isolated on admis-
sion. Despite the number of patients presenting with a
pre-existing MRSA load, postoperative infective com-
plications only occurred in those patients acquiring
MRSA whilst in hospital. It is thus desirable to identify
MRSA positive patients early to allow isolation on
admission or eradication of MRSA prior to admission.
This not only reduces the risk to these individual
patients but also to reduce the size of the MRSA pool
available for transfer to other patients in the hospital.
There are a number of financial and political
reasons to reduce the length of hospital stay including
reduction of the length of waiting lists and increased
patient throughput. The finding that length of
hospital stay is the single most important determinant
of MRSA acquisition and an appreciation of theEur J Vasc Endovasc Surg Vol 25, February 2003mortality and morbidity caused by MRSA is perhaps
a more laudable reason to minimise the length of time
a patient is in hospital. To this end, pre-assessment
outpatient visits allowing admission on the day of
surgery and a move towards early discharge in appro-
priate cases is to be encouraged. A further issue is the
accuracy of a single set of screening swabs, which are
not 100% sensitive. The method we describe has been
demonstrated to be 96% sensitive for detection of
MRSA but this does mean that the potential to fail to
identify MRSA carriage exists. This obviously means
that selective eradication of MRSA based on a pre-
operative screen will not prevent MRSA from being
brought into the hospital. However, as a general
guide to the timing of MRSA acquisition we feel the
sensitivity is acceptable.
In summary, it appears that 20% of vascular patients
are MRSA positive, the majority acquiring MRSA in
the postoperative period. The overall level of bacterial
infection on a vascular ward is high. We would
recommend a high level of suspicion in patients devel-
oping a postoperative infective complication and
advocate careful hand hygiene in those individuals
caring for patients.
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